Showing results (11-20 of 203) with videos related to
Sort By:
Pageof 21
Current Drug Targets|June 13, 2009
Liver fibrosis and therapeutic strategies: the goal for improving metabolismClara Balsano, Anna Alisi, Valerio NobiliJournal of Pediatric Gastroenterology and Nutrition|July 6, 2016
Pediatric NAFLD: the Future role of Patient-Tailored Probiotics TherapyLorenza Putignani, Anna Alisi, Valerio NobiliExpert Opinion on Medical Diagnostics|March 14, 2013
Transient elastography and serum biomarkers: two-step screening methods for liver fibrosis in non-alcoholic fatty liver disease before liver biopsyAnna Alisi, Sara Ceccarelli, Valerio NobiliDrugs|May 27, 2020
The G-Quadruplex/Helicase World as a Potential Antiviral Approach Against COVID-19Nadia Panera, Alberto Eugenio Tozzi, Anna AlisiExpert Review of Gastroenterology & Hepatology|September 28, 2013
Is there any link between dietary pattern and development of nonalcoholic fatty liver disease in adolescence? An expert reviewDaniela Liccardo, Anna Alisi, Gilda Porta, et al.Annals of Hepatology|April 22, 2009
Association between type two diabetes and non-alcoholic fatty liver disease in youthAnna Alisi, Melania Manco, Nadia Panera, et al.Biomarkers in Medicine|December 12, 2012
Circulating miRNA profiling to identify biomarkers of dysmetabolismSara Tomaselli, Nadia Panera, Angela Gallo, et al.Pediatric Endocrinology Reviews : PER|February 10, 2009
Low birth weight and catch-up-growth associated with metabolic syndrome: a ten year systematic reviewValerio Nobili, Anna Alisi, Nadia Panera, et al.Expert Review of Gastroenterology & Hepatology|July 28, 2020
Noninvasive diagnostic tools for pediatric NAFLD: where are we now?Antonella Mosca, Nadia Panera, Annalisa Crudele, et al.International Journal of Endocrinology|December 23, 2011
Intrauterine growth retardation and nonalcoholic Fatty liver disease in childrenAnna Alisi, Nadia Panera, Carlo Agostoni, et al.Pageof 21